CompuGroup Medical SE & Co. KGaA

COP

Equity

ISIN DE000A288904 / Valor 55499718

Xetra (2024-11-26)

EUR 15.20+1.47%

CompuGroup Medical SE & Co. KGaA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

CompuGroup Medical SE & Co. KGaA is a global healthcare technology company that specializes in developing software solutions aimed at enhancing the medical and administrative operations within the healthcare sector. The company's portfolio includes a wide range of products and services designed to facilitate electronic communication between healthcare providers and patients, thereby improving the efficiency of healthcare delivery. By focusing on the digitalization of healthcare processes, CompuGroup Medical aims to streamline workflows for medical professionals, enabling better patient care and optimizing administrative tasks. The company's solutions cater to a diverse clientele, including hospitals, general practitioners, pharmacies, and other healthcare facilities, underscoring its role in advancing the digital transformation of the healthcare industry.

Summarized from source with an LLMView SourceSector: Technology

Revenue Decline

CompuGroup Medical SE & Co. KGaA reported a 6% decline in revenue for the first half of the fiscal year 2024, amounting to EUR 562 million compared to EUR 595 million in the same period of the previous year. This decrease was primarily due to one-time effects related to telematics infrastructure in the prior year.

Recurring Revenue Increase

Despite the overall revenue decline, CompuGroup Medical SE & Co. KGaA saw a 6% increase in recurring revenues, reaching EUR 423 million in the first half of 2024, up from EUR 401 million in the same period of the previous year. Recurring revenues now constitute 75% of the total revenue, compared to 67% previously.

EBITDA and EPS

The adjusted EBITDA for CompuGroup Medical SE & Co. KGaA decreased by 14% to EUR 114 million in the first half of 2024, down from EUR 133 million in the previous year. Additionally, the adjusted earnings per share (EPS) fell to EUR 0.81 from EUR 1.07 in the same period last year.

Free Cash Flow

CompuGroup Medical SE & Co. KGaA's free cash flow significantly dropped to EUR 39 million in the first half of 2024, compared to EUR 83 million in the same period of the previous year. This decline reflects the company's increased investments and operational changes.

Debt Levels

The net debt of CompuGroup Medical SE & Co. KGaA rose from EUR 703 million at the end of 2023 to EUR 779 million by the end of June 2024. Consequently, the debt ratio increased from 2.8x at the end of 2023 to 3.3x by mid-2024.

Summarized from source with an LLMView Source

Key figures

-59.3%1Y

-77.7%3Y

-75.2%5Y

Performance

54.3%1Y

43.2%3Y

40.9%5Y

Volatility